Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular, cytogenetic and genetic abnormalities in MDS and secondary AML.

Cancer treatment and research - 1 Jan 2001

Padua R A, McGlynn A, McGlynn H

Abstract excerpt

Myelodysplasia (MDS) is a clonal disease, which increases with age, suggesting that multiple steps are required for the evolution of the condition. Approximately 30% of MDS evolve into acute myelogenous leukemia (AML). In this review, we intend to delineate the genetic events, which may drive this sequence and therefore we will focus primarily on cytogenetic abnormalities where the genes have been identified and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aneuploidy
Share to Chromosome Painting
Share to Chromosomes, Human

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Growth Substances

Share to Leukemia, Myeloid

Share to Myelodysplastic Syndromes

Share to Receptors, Growth Factor

Share to Trisomy

Source

Identifiers

PMID: 11702597
DOI: 10.1007/978-1-4615-1463-3_8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular, cytogenetic and genetic abnormalities in MDS and secondary AML.PMID 11702597Read ↗

Myelodysplastic syndromes: molecular pathogenesis and genomic changes.Semantic proximity Read ↗

Molecular mechanisms of the progression of myelodysplastic syndrome to secondary acute myeloid leukaemia and implication for therapySemantic proximity Read ↗

Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the diseaseSemantic proximity Read ↗

Genetic and epigenetic pathways in myelodysplastic syndromes: A brief overview.Semantic proximity Read ↗

Important features of myelodysplastic syndrome.Semantic proximity Read ↗

Genetics of progression from MDS to secondary leukemia.Semantic proximity Read ↗

Molecular and genetic features of myelodysplastic syndromes.Semantic proximity Read ↗

Update on cytogenetic and molecular changes in myelodysplastic syndromes.Semantic proximity Read ↗

Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia.Semantic proximity Read ↗

The myelodysplastic syndromes: diagnosis, molecular biology and risk assessment.Semantic proximity Read ↗

The genetic and molecular pathogenesis of myelodysplastic syndromes.Semantic proximity Read ↗

Pathophysiology of MDS: genomic aberrations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.